CHU Amiens
Amiens, 80480, France
NCT Number: NCT04665778
The COVID-19 outbreak leads to optimize the pathway in emergency departments. The length of time spent in the Emergency Department is linked to the morbi-mortality and the risk of COVID-19 transmission. The Amiens-Picardy University Hospital has developed an application (3P-U) that optimizes patient flow. It identifies the need of hospitalization and problems on the care path. Patients are categorized in high risk or not high probabilty of hospitalization. The main goal of this project is to evaluate the impact on the patient flow of the 3P-U application. Early lookup of bed for high probability hospitalization should be linked to a reduced time of length. This study will compare the time of length between this both groups.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Amiens, 80480, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient in high risk of hospitalization group benefits a dedicated process to find and book a bedroom
Time frame: up to 3 months
Variation of the length of stay between high probability of hospitalization group and not high risk of hospitalization group.
Centre Hospitalier Universitaire, Amiens
Other
Acronym: 3PU-SSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial DetailsNCT04900233
Appendicitis, COVID-19
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
View Trial DetailsNCT04669925
COVID-19, Coronaviridae Infections
Bergamo, Italy
View Trial DetailsNCT04816630
Adults, COVID-19
St Louis, Missouri, United States
View Trial Details